These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 10416482)

  • 41. Global view of antimicrobial resistance. Findings of the SENTRY Antimicrobial Surveillance Program, 1997-1999.
    Pfaller MA; Jones RN
    Postgrad Med; 2001 Feb; 109(2 Suppl):10-21. PubMed ID: 19667553
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Microbiological and pharmacodynamic considerations in the treatment of infection due to antimicrobial-resistant Streptococcus pneumoniae.
    Appelbaum PC
    Clin Infect Dis; 2000 Aug; 31 Suppl 2():S29-34. PubMed ID: 10984325
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evidence for moxifloxacin in community-acquired pneumonia: the impact of pharmaco-economic considerations on guidelines.
    Simoens S
    Curr Med Res Opin; 2009 Oct; 25(10):2447-57. PubMed ID: 19678752
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preventing the spread of antimicrobial resistance among bacterial respiratory pathogens in industrialized countries: the case for judicious antimicrobial use.
    Schwartz B
    Clin Infect Dis; 1999 Feb; 28(2):211-3. PubMed ID: 10064228
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reducing antimicrobial resistance in the community by restricting prescribing: can it be done?
    Enne VI
    J Antimicrob Chemother; 2010 Feb; 65(2):179-82. PubMed ID: 20008449
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Control of antibiotic-resistant bacteria: memorandum from a WHO meeting. World Health Organization Scientific Working Group on Antimicrobial Resistance.
    Am J Hosp Pharm; 1984 Jul; 41(7):1329-37. PubMed ID: 6540519
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Health council report: "Antimicrobial growth promoters"].
    Goettsch W; Degener JE
    Tijdschr Diergeneeskd; 1999 Mar; 124(5):142-4. PubMed ID: 10084197
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Anglo-Saxon guidelines for the treatment of community-acquired pneumonia also applicable in The Netherlands].
    Peetermans WE; Verhaegen J
    Ned Tijdschr Geneeskd; 1997 Nov; 141(45):2200-1; author reply 2201-2. PubMed ID: 9550807
    [No Abstract]   [Full Text] [Related]  

  • 49. Antibiotic resistance: an editorial review with recommendations.
    Rosen T
    J Drugs Dermatol; 2011 Jul; 10(7):724-33. PubMed ID: 21720654
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Microbial resistance: what is to be done? Information from the panel of experts].
    Mochales FB; Castelló RB; Marqués JC; Rodríguez LD; Alemany XG; Rodríguez JA; Beato EP; Gorricho BP; Trallero EP; Pastor GP
    Rev Esp Salud Publica; 1995; 69(6):445-61. PubMed ID: 8789357
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Hetty van Beers, director SDa: SDa determines the guidelines for responsible antibiotic use, not the government!].
    Swormink BK
    Tijdschr Diergeneeskd; 2012 Nov; 137(11):742-3. PubMed ID: 23213827
    [No Abstract]   [Full Text] [Related]  

  • 52. Epidemiology of antibiotic resistance.
    Palmer DL
    J Med; 1980; 11(4):255-62. PubMed ID: 6943257
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rising antimicrobial resistance: a strong reason to reduce excessive antimicrobial consumption in New Zealand.
    Thomas MG; Smith AJ; Tilyard M
    N Z Med J; 2014 May; 127(1394):72-84. PubMed ID: 24929573
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antibiotic therapy in 1994: mechanisms of resistance.
    Barg N
    Hosp Formul; 1994 Aug; 29 Suppl 3():S13-7. PubMed ID: 10136345
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bugs and drugs: antibiotic resistance in the 1990s.
    Rickman LS
    Todays OR Nurse; 1994; 16(5):7-12. PubMed ID: 7974655
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adjuvant strategies for potentiation of antibiotics to overcome antimicrobial resistance.
    Pieren M; Tigges M
    Curr Opin Pharmacol; 2012 Oct; 12(5):551-5. PubMed ID: 22835931
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of antimicrobial resistance on regulatory policies in veterinary medicine: status report.
    Tollefson L; Flynn WT
    AAPS PharmSci; 2002; 4(4):E37. PubMed ID: 12646009
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Community factors in the development of antibiotic resistance.
    Larson E
    Annu Rev Public Health; 2007; 28():435-47. PubMed ID: 17094768
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Antibiotic use in farm animals in 2009].
    Tijdschr Diergeneeskd; 2010 Sep; 135(17):644-5. PubMed ID: 20865968
    [No Abstract]   [Full Text] [Related]  

  • 60. [The use of prophylactic antibiotics in common infections in the community].
    Bisharat N; Katz R
    Harefuah; 1997 Jun; 132(11):792-6. PubMed ID: 9223825
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.